FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Terminating Winnes Debarment

[ Price : $8.95]

Federal Register notice: FDA grants a special termination of the debarment of David Winne due to his cooperation with federal offi...

Panel Backs Sickle Cell Gene Therapy Safety

[ Price : $8.95]

FDAs Cellular, Tissue, and Gene Therapies Advisory Committee supports Vertex Pharmaceuticals and CRISPR Therapeutics safety assess...

FDA Expects Increasing Cannabis Research

[ Price : $8.95]

An FDA post reviews 50 years of agency involvement in cannabis research and predicts the increase seen in recent years will contin...

Unlicensed Wholesaler Sentenced to Prison

[ Price : $8.95]

A Florida federal judge sentences Marina Sievert to two years in federal prison for mail fraud and introducing into interstate com...

Tonix Shuts Down Depression Drug Development

[ Price : $8.95]

Tonix Pharmaceuticals discontinues the development program for major depressive disorder candidate TNX-601 ER based on disappointi...

New FDA Off-Label Guide Has Challenges: Lawyers

[ Price : $8.95]

Sidley Austin attorneys pull five takeaways, including challenges, from a recent FDA draft guidance on off-label communications be...

FDA Sends 8-item 483 to NATCO Pharma

[ Price : $8.95]

FDA issues NATCO Pharma an eight-item Form FDA-483 after concluding an inspection of the firms Telangana, India, manufacturing fac...

API CGMP Deviations at Ali Pharmaceutical

[ Price : $8.95]

FDA warns Omaha, NE-based Ali Pharmaceutical Manufacturing about significant CGMP deviations for active pharmaceutical ingredients...

Objectionable Conditions at BTS Research

[ Price : $8.95]

FDA warns San Diego, CA-based Samm Solutions about objectionable conditions in its role as the testing facility for two nonclinica...

X4 Pharma NDA Accepted for WHIM Syndrome

[ Price : $8.95]

FDA accepts for priority review an X4 Pharmaceuticals NDA for once-daily, oral mavorixafor to treat individuals aged 12 and older ...